Researchers have called for more research to determine the best ways to keep SARS-CoV-19 out of the water cycle. They also suggest that developed nations should finance water treatment systems in the developing world to help prevent future COVID-19 pandemics.
Turning a brittle oxide into a flexible membrane and stretching it on a tiny apparatus flipped it from a conducting to an insulating state and changed its magnetic properties. The technique can be used to study and design a broad range of materials for use in things like sensors and detectors.
Low-carbon technologies that are smaller scale, more affordable, and can be mass deployed are more likely to enable a faster transition to net-zero emissions, according to a new study. Innovations ranging from solar panels to electric bikes also have lower investment risks, greater potential for improvement in both cost and performance, and more scope for reducing energy demand — key attributes that will help accelerate progress on decarbonization.
After The Wall Street Journal first broke the news this week, Amgen and new partner Adaptive Biotechnologies have confirmed they are the latest pharma-biotech duo joining forces against the pandemic.
A new and unproved COVID-19 cell therapy from a New Jersey biotech has been given a quick trial approval by the FDA, coming just days after President Donald Trump’s personal attorney and former New York City Mayor Rudy Giuliani pushed for the med to be trialed ASAP.
Under terms of the deal, Aurobindo would pay $900 million upfront with an additional $100 million in milestone payments. However, in a filing with the Securities and Exchange Commission, the company announced it had terminated that agreement.
With all the similarities, it should be emphasized that there are several significant differences between the two pandemics.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
Scientists have announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine — delivered through a fingertip-sized patch — produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.